Rosids

Delta Verde Laboratory Positioned for Dynamic Growth in the Cannabis Industry

Retrieved on: 
Friday, February 19, 2021

Delta Verde Laboratory , an Arizona based analytical testing lab, is positioned for dynamic and accelerated growth in the cannabis industry and has recently been granted additional compliance testing approvals in areas of both chemistry and microbiology.

Key Points: 
  • Delta Verde Laboratory , an Arizona based analytical testing lab, is positioned for dynamic and accelerated growth in the cannabis industry and has recently been granted additional compliance testing approvals in areas of both chemistry and microbiology.
  • Founded in 2014 by experienced chemist Dr. James Clark, Delta Verde Laboratory has pioneered advanced analytical chemistry and microbiology procedures for analyzing cannabis and cannabis infused products, which are often complex matrices.
  • The leading role we play in the lab adds value to the industry by ensuring that cannabis and cannabis infused products can be accurately labeled and that customers can experience their favorite brands in consistent ways, says Nate Allen, owner of Delta Verde Laboratory.
  • Since its founding in 2014, Delta Verde Laboratory has become a highly specialized and ISO17025 accredited analytical testing lab that is dedicated to the fast, accurate, and affordable compliance and informational testing of cannabis and cannabis infused products.

Autoflower Hemp Will Rule Emerging CBD Global Powerhouse Regions of South East Asia and Latin America

Retrieved on: 
Thursday, February 18, 2021

LONGMONT, Colo., Feb. 18, 2021 /PRNewswire/ --Hemp seed breeder Trilogene Seeds releases three new autoflower hemp varietals for 2021 seed sales, a bid to meet the needs of hemp growers in regions like Thailand and Latin America predicted to dominate the future of global CBD hemp production.

Key Points: 
  • LONGMONT, Colo., Feb. 18, 2021 /PRNewswire/ --Hemp seed breeder Trilogene Seeds releases three new autoflower hemp varietals for 2021 seed sales, a bid to meet the needs of hemp growers in regions like Thailand and Latin America predicted to dominate the future of global CBD hemp production.
  • In Latin America, several countries, including Chile, Mexico, Colombia, Brazil, Argentina, Peru and Uruguay, have legalized hemp production.
  • Autoflower hemp, orCannabis ruderalis, does not depend on daylight hours to trigger flowering, unlike the traditional hemp species,Cannabis sativa.
  • Trilogene begin breeding autoflower specifically for tropical regions like Thailand, Argentina and Zimbabwe anticipating the needs of an emerging global hemp market, Haddad says.

Enviro-Serv (OTC-EVSV) Retains Professional Real Estate Company to Secure Location for Indoor Cannabis Grow Facility in Michigan

Retrieved on: 
Wednesday, February 17, 2021

Chris Trina, Enviro-Serv, Inc.Chairman and CEO, revealed that, We have retained a professional cannabis real estate company, Michigan Cannabis Properties, ( WWW.MICHIGANCANNABISPROPERTIES.COM ), to secure a proper location for the upper Michigan grow site.

Key Points: 
  • Chris Trina, Enviro-Serv, Inc.Chairman and CEO, revealed that, We have retained a professional cannabis real estate company, Michigan Cannabis Properties, ( WWW.MICHIGANCANNABISPROPERTIES.COM ), to secure a proper location for the upper Michigan grow site.
  • The property to be acquired will house our growing equipment in an indoor cannabis grow facility.
  • Because Michigan legalized state-licensed sales of recreational cannabis in December 2019, the local cannabis economy can be expected to grow significantly in years to come.
  • With Enviro-Servs current position, the company stands to be a strong player in the burgeoning local cannabis market.

New Legislation Continues the Expansion of the Cannabis Market

Retrieved on: 
Thursday, February 11, 2021

In the U.S, New Jersey became the most recent state where two key legislative budget committees advanced a recreational cannabis implementation measure.

Key Points: 
  • In the U.S, New Jersey became the most recent state where two key legislative budget committees advanced a recreational cannabis implementation measure.
  • However, thanks to legalization, cannabis products for adult-use (recreational purposes) are expected to gain market share in the coming years.
  • Overall, the global legal cannabis market size is now expected to reach USD 73.6 Billion by 2027, according to a report published by Grand View Research.
  • Trulieve Cannabis Corp.(OTCQX: TCNNF) (CSE: TRUL) announced last week the expansion of its Blue River extracts lineup with Cold Cure Live Rosin.

New Legislation Continues the Expansion of the Cannabis Market

Retrieved on: 
Thursday, February 11, 2021

In the U.S, New Jersey became the most recent state where two key legislative budget committees advanced a recreational cannabis implementation measure.

Key Points: 
  • In the U.S, New Jersey became the most recent state where two key legislative budget committees advanced a recreational cannabis implementation measure.
  • However, thanks to legalization, cannabis products for adult-use (recreational purposes) are expected to gain market share in the coming years.
  • Overall, the global legal cannabis market size is now expected to reach USD 73.6 Billion by 2027, according to a report published by Grand View Research.
  • Trulieve Cannabis Corp.(OTCQX: TCNNF) (CSE: TRUL) announced last week the expansion of its Blue River extracts lineup with Cold Cure Live Rosin.

Fiore Cannabis Continues Strategic Program to Refocus on Core Assets

Retrieved on: 
Thursday, February 11, 2021

Kelowna, British Columbia--(Newsfile Corp. - February 11, 2021) - Fiore Cannabis (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or the "Company"), a licensed multi-state cannabis cultivator, producer and retailer, today announced that it continues to aggressively pursue its program to refocus on core assets in the key operating markets of Nevada and California.

Key Points: 
  • Kelowna, British Columbia--(Newsfile Corp. - February 11, 2021) - Fiore Cannabis (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or the "Company"), a licensed multi-state cannabis cultivator, producer and retailer, today announced that it continues to aggressively pursue its program to refocus on core assets in the key operating markets of Nevada and California.
  • We have an approach to the cultivation, production and retail of cannabis at Fiore that is all about top-quality products, strong branding and generating solid financial returns," said Erik Anderson, President and CEO of Fiore Cannabis.
  • "It's an easy decision to divest assets in Washington and British Columbia and to focus tightly on our core assets.
  • Fiore Cannabis (CSE: FIOR) (OTCQX: FIORF) is a publicly traded company that has been investing in the development of medical and recreational cannabis products since 2014.

Mapping Key DNA Markers for the Autoflower Trait to Accelerate Breeding Elite Hemp and Cannabis Varieties

Retrieved on: 
Wednesday, February 10, 2021

Now, the companies have successfully mapped several key genes including the autoflowering gene, which is a highly desired trait and of great interest for the hemp and cannabis industries.

Key Points: 
  • Now, the companies have successfully mapped several key genes including the autoflowering gene, which is a highly desired trait and of great interest for the hemp and cannabis industries.
  • NRGene estimates, that following the development of DNA markers for the autoflowering trait, it is now possible to integrate this trait into any hemp and cannabis variety within 12 to 18 months.
  • Using these markers, Kayagene can now reduce, by 50%, the time required to incorporate the autoflower trait into their proprietary elite cannabis and hemp varieties.
  • Kayagene is employing these advanced techniques using NRGenes genomics tools and our vast experience with breeding, to develop improved elite hemp and cannabis varieties.

aerīz Goes Adult-Use With its Dispensary, Marigold, as Arizona Switching From Medical Marijuana Only State to Recreational-Use Cannabis

Retrieved on: 
Thursday, February 4, 2021

Marigold received approval from the Arizona Department of Health Services to serve adult-use, recreational customers aged 21 and over.

Key Points: 
  • Marigold received approval from the Arizona Department of Health Services to serve adult-use, recreational customers aged 21 and over.
  • Marigold Dispensary is located at 2601 W Dunlap in Phoenix and is a proud to be supported by the aerz aeroponic cultivation center, also in Phoenix.
  • aerz is the largest multistate aeroponic cannabis operator in the United States, with a mission to grow and produce the cleanest cannabis products available.
  • With operations in Arizona, Illinois and California, aerz is thrilled to service both medical and recreational consumers nationwide.

The Flowr Corporation Announces Entry into Quebec

Retrieved on: 
Thursday, February 4, 2021

Flowr partners with ROSE LifeScience Inc., a local cannabis producer in Quebec.

Key Points: 
  • Flowr partners with ROSE LifeScience Inc., a local cannabis producer in Quebec.
  • TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (Flowr or the Company) is pleased to announce that it has entered the Province of Quebec with its first commercial orders for its award-winning BC Pink Kush and its newest strain BC Black Cherry.
  • Flowr has shipped dried cannabis flower for the first time into the Quebec market through a distribution partnership with ROSE LifeScience Inc. (ROSE).
  • For more information, please visit flowrcorp.com or follow Flowr on Twitter: @FlowrCanada and LinkedIn: The Flowr Corporation .

Canntab Grants Options

Retrieved on: 
Wednesday, February 3, 2021

Toronto, Ontario--(Newsfile Corp. - February 3, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab") announces that it has granted, in accordance with the Company's stock option plan, an aggregate of 50,000 options to purchase common shares of the Company to a consultant of the Company.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - February 3, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab") announces that it has granted, in accordance with the Company's stock option plan, an aggregate of 50,000 options to purchase common shares of the Company to a consultant of the Company.
  • Canntab Therapeutics is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations.
  • Canntab holds a Cannabis Standard Processing & Sales for Medical Purposes License, a Cannabis Research License, and an Industrial Hemp License from Health Canada.
  • Canntab trades on the Canadian Securities Exchange under the symbol PILL, on the OTCQB under the symbol CTABF, and on the Frankfurt Stock Exchange under the symbol TBF1.